For these reasons, we decided to undertake formal penetrance analysis to estimate cancer risks associated with the BRCA1 c.5017_5019del (p.His1673del) variant, to experimentally test the effect of the variant on BRCA1 protein function, and to re‐assess its clinical significance using updated classification protocols. Here, BRCA1 is linked to cancer.